BUDGET IMPACT OF NIRAPARIB AS MAINTENANCE TREATMENT FOR MEDICARE PATIENTS WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER WHO ARE IN COMPLETE OR PARTIAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY

被引：0
|
作者：
Neeser, K. [1 ]
O'Neil, W. M. [1 ]
Stern, L. [1 ]
机构：
[1] Analyt Laser, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN51
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [1] Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy
    Neeser, Kurt
    O'Neil, William M.
    Stern, Lee
    Harrow, Brooke
    Travers, Karin
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (08) : 577 - 587
  • [2] FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
    Ison, Gwynn
    Howie, Lynn J.
    Amiri-Kordestani, Laleh
    Zhang, Lijun
    Tang, Shenghui
    Sridhara, Rajeshwari
    Pierre, Vadryn
    Charlab, Rosane
    Ramamoorthy, Anuradha
    Song, Pengfei
    Li, Fang
    Yu, Jingyu
    Manheng, Wimolnut
    Palmby, Todd R.
    Ghosh, Soma
    Horne, Hisani N.
    Lee, Eunice Y.
    Philip, Reena
    Dave, Kaushalkumar
    Chen, Xiao Hong
    Kelly, Sharon L.
    Janoria, Kumar G.
    Banerjee, Anamitro
    Eradiri, Okponanabofa
    Dinin, Jeannette
    Goldberg, Kirsten B.
    Pierce, William F.
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4066 - 4071
  • [3] Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Kerliu, Lloreta
    Myruski, Samantha
    Bhatti, Afeefa
    Soni, Priyal
    Petrosius, Paulius
    Pervanas, Helen C.
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 1010 - 1015
  • [4] NEW MAINTENANCE TREATMENT FOR RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (08) : 25 - 26
  • [5] Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
    Jeerakornpassawat, Dhammapoj
    Suprasert, Prapaporn
    OBSTETRICS & GYNECOLOGY SCIENCE, 2020, 63 (01) : 55 - 63
  • [6] Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Kathleen Moore
    John K. Chan
    Angeles Alvarez Secord
    Manish R. Patel
    Timothy Callahan
    Wei Guo
    Zhi-Yi Zhang
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 717 - 726
  • [7] Niraparib in the maintenance treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: safety and efficacy
    Liu, Marisa C.
    Sutedja, Joyce
    Tewari, Krishnansu S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) : 475 - 480
  • [8] Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Moore, Kathleen
    Chan, John K.
    Secord, Angeles Alvarez
    Patel, Manish R.
    Callahan, Timothy
    Guo, Wei
    Zhang, Zhi-Yi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (04) : 717 - 726
  • [9] HEMATOLOGIC MARKERS OF SURVIVAL OUTCOME IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    Suprasert, P.
    Jeerakornpassawat, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A523 - A523
  • [10] Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
    del Campo, Josep M.
    Matulonis, Ursula A.
    Malander, Susanne
    Provencher, Diane
    Mahner, Sven
    Follana, Philippe
    Waters, Justin
    Berek, Jonathan S.
    Woie, Kathrine
    Oza, Amit M.
    Canzler, Ulrich
    Gil-Martin, Marta
    Lesoin, Anne
    Monk, Bradley J.
    Lund, Bente
    Gilbert, Lucy
    Wenham, Robert M.
    Benigno, Benedict
    Arora, Sujata
    Hazard, Sebastien J.
    Mirza, Mansoor R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) : 2968 - +
12345